Previous Article | Next Article ![]()
Journal of Clinical Microbiology, April 2002, p. 1225-1229, Vol. 40, No. 4
0095-1137/02/$04.00+0 DOI: 10.1128/JCM.40.4.1225-1229.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Instituto Nacional de Enfermedades Infecciosas, ANLIS"Dr. Carlos G. Malbrán," (1281) Buenos Aires,1 Policlinico Neuquén, (8300) Neuquén, Argentina,2 National Laboratory for Enteric Pathogens, National Microbiology Laboratory, Canadian Science Centre for Human and Animal Health, Winnipeg, R3E 3R2, Manitoba, Canada3
Received 29 October 2001/ Accepted 19 December 2001
|
|
|---|
|
|
|---|
There are four distinct categories of Escherichia coli causing diarrheal disease: enteropathogenic E. coli (EPEC), enterotoxigenic E. coli (ETEC), enteroinvasive E. coli, and enterohemorrhagic E. coli (EHEC). Epidemiologic studies have also implicated two additional categories, enteroaggregative and diffusely adherent E. coli. However, outbreaks of nosocomial diarrheal disease acquired by infants have traditionally been associated with EPEC, while ETEC predominates in the young in developing countries. Sporadic cases and outbreaks of food-borne disease often associated with hemorrhagic colitis and hemolytic-uremic syndrome are caused by EHEC strains that produce Shiga-like toxins and enterohemolysins (12, 16). Serotyping and molecular markers for E. coli have been used successfully in epidemiologic investigations associated with outbreaks of disease. Pulsed-field gel electrophoresis (PFGE) provides a useful molecular subtyping method which demonstrates that isolates of similar serotype from a common source can be characterized based on identical banding patterns. Epidemiologically, this is highly significant in terms of differentiating between outbreak-related strains and non-outbreak-related strains (2).
Most of the reported E. coli outbreaks in neonates have been associated with diarrhea or pyelonephritis (6). It is known that the prevalence of serogroups O1, O2, O4, O5, O18, O20, O25, and O75 in the human fecal flora is greater than that of other serogroups, and it is thought that this is in some way due to the capacity of some of these serogroups to persist in the bowel (19).
Frequently, cases in the community precede hospital outbreaks, and these usually result from the admission to the hospital of a baby with either established disease or a carrier state in which the pathogenic strain is excreted. An outbreak of bloody diarrhea due to E. coli O18ac:H31 occurred in the neonatal nursery ward of the Policlínico Neuquén. This outbreak was not associated with disease in the community and occurred in the hospital despite a strict program established for the prevention of nosocomial infections.
|
|
|---|
The index case, a 5-day-old female patient, was admitted with a diagnosis of an abdominal tumor to the intermediate care unit on 7 October in order to undergo scheduled surgery. On 9 October the patient exhibited bloody diarrhea in the absence of other clinical symptoms, including fever, vomiting, abdominal pain, or dehydration. Bacteriologic culture of stool yielded polymicrobial flora with no recognized enteropathogens. The child was discharged on 11 October. Subsequently, five of six neonatal patients presenting with diarrhea showed abundant macroscopic blood in their stools (Table 1). These patients exhibited neither signs of inflammatory bowel disease nor general compromise. Another symptomatic patient (case F) with Down's syndrome died 3 days after birth due to necrotizing enterocolitis (NEC) grade III with intestinal perforation, peritonitis, and septicemia. Three of the six patients (cases A to C) involved in the outbreak were in the hospital at the same time as the index case.
|
View this table: [in a new window] |
TABLE 1. Strains recovered during the outbreak and prevalence study periods
|
Microbiological examination. Stool specimens from all symptomatic and asymptomatic children and from all of the clinical staff were collected and processed at the hospital microbiology laboratory for E. coli, Salmonella, Shigella, Vibrio, Aeromonas, and Campylobacter species as well as for rotavirus using an enzyme-linked immunosorbent assay kit (Abbott Laboratories, Abbott Park, Ill.). For E. coli detection, each stool sample was plated on to MacConkey agar and sorbitol MacConkey agar (Difco Laboratories, Detroit, Mich.). From each case, five colonies, characterized as E. coli by standard biochemical tests (7), were selected, cultured on nutrient agar slants, and sent to the Instituto Nacional de Enfermedades Infecciosas reference laboratory for further investigations.
All isolates (seven from symptomatic patients, six from asymptomatic patients, and two from staff) were tested by agglutination assay using specific O antisera: O1, O6, O8, O15, O18, O20, O25, O26, O27, O28ac, O29, O44, O55, O63, O78, O86a, O111, O112ac, O114, O115, O119, O124, O125, O126, O127a, O128, O136, O142, O143, O144, O146, O148, O151, O152, O153, O157, O158, O159, O164, O166, O167, O168, and O169 (Denka Seiken, Co., Ltd., Tokyo, Japan). Complete serotyping was performed at the National Laboratory for Enteric Pathogens, National Microbiology Laboratory, Winnipeg, Canada. Antimicrobial susceptibility patterns were established according to the Kirby-Bauer method for ampicillin, carbenicillin, cefixime, cefotaxime, cefuroxime, cephalothin, colistin, chloramphenicol, gentamicin, nalidixic acid, norfloxacin, streptomycin, tetracycline, and trimethoprim-sulfamethoxazole, according to NCCLS standards and methods (12a).
Detection of virulence factors. Isolates from seven neonates associated with the outbreak (cases A to G), together with those recovered during the prevalence study period, including six from asymptomatic infants not related to the outbreak (cases H to M) and two from staff members (cases N and O), were examined at the Instituto Nacional de Enfermedades Infecciosas and National Laboratory for Enteric Pathogens for the presence of established E. coli virulence factors.
Cytotoxic activity was assayed on Vero cells according to the method of Karmali et al. (10). Specific monoclonal antibodies (13C4 and BC5BB12) against Shiga toxins 1 and 2 (verotoxins 1 and 2), respectively, were used in neutralization testing and were kindly provided by Nancy Strockbine, Centers for Disease Control and Prevention, Atlanta, Ga. Diarrheagenic E. coli virulence factors, including bundle-forming pilus (bfp), the attaching-and-effacing gene (eaeA), Stx1 and Stx2, and DA fimbriae (daa) were analyzed by colony blot hybridization assay under stringent washing conditions with specific UTP-digoxigenin-labeled gene probes (kindly provided by J. Kaper and J. Nataro, Center for Vaccine Development, University of Maryland, School of Medicine, Baltimore, Md.) (20). Heat-stable and heat-labile toxin production of ETEC was analyzed by enzyme-linked immunosorbent assay (3).
The outer membrane protein of enteroinvasive E. coli was studied by enzyme-linked immunosorbent assay (4). A modified form of the HeLa cell adherence assay described by Scaletsky et al. (15) was performed to characterize E. coli according to the localized, diffuse, and aggregative patterns published by Cravioto et al. (5).
Enteroaggregative E. coli and EHEC-hlyA detection was performed by PCR as described by Schmidt et al. (17). Furthermore, all 15 isolates were analyzed by PCR for the presence of the enterohemolysin gene ehl1, which is genetically unrelated to EHEC-hlyA (21.8% sequence similarity). ehl1 is frequently expressed by E. coli strains that produce Shiga-like toxins and in toxin-negative EPEC strains (18). The oligonucleotide primers used in this study were forward (5'-CTCCTGATGTGCTTCTCGGTGTTT-3') and reverse (5'-AGGCCATCAGCATTTCTTCT-3'). These amplified a 195-bp fragment from the ehl1 allele and were designed based on enterohemolysin sequence 1 (GenBank accession no. X70047). The PCR procedure and conditions used in this study were as previously described (16). All isolates were further examined for a variety of additional virulence factors, including pInv; pCDV432; CDT I, II, and III; CNF; ial; IpaH; K1; and adherence patterns.
RAPD-PCR. Random amplified polymorphic DNA (RAPD)-PCR was carried out as described by Pacheco et al. (14) in 30-µl reaction volumes containing 3 µl of undiluted, boiled DNA containing 20 pmol of each primer (254, 5'-CCGCAGCCAA-3'; 256, 5'-AACGCGCAAC-3'; 257, 5'-GTGGATGCGA-3'; and 258, 5'-AGCCAGTTTC-3'), 2 U of Taq DNA polymerase (Gibco BRL, Life Technologies Ltd., Gaithersburg, Md.), and a 250 µM concentration of each deoxynucleoside triphosphate (Gibco BRL) in 10 mM Tris HCl (pH 8.4), 50 mM KCl, and 3 mM MgCl2. Amplification reactions were performed in a Biometra apparatus (Biometra GmbH, Göttingen, Germany). Reaction products were analyzed by electrophoresis on 1.2% agarose (Bio-Rad Laboratories, Hercules, Calif.).
PFGE. PFGE was performed as described by Barrett et al. (2), with minor modifications. In brief, each bacterial cell suspension (optical density at 600 nm, 1.35) was embedded in low-melting-temperature agarose (Gibco BRL). The plugs were incubated at 50°C in lysis buffer overnight and sliced into aliquots 2 mm in thickness. The DNA-containing plugs were subjected to restriction endonuclease digestion with 20 U of XbaI (Promega Corp., Madison, Wis.) at 37°C for 18 h.
Restriction fragments were separated by electrophoresis through 1% PFGE agarose (Bio-Rad) in 0.5x Tris-borate-EDTA buffer at 14°C at 200 V in a CHEFF DR III apparatus (Bio-Rad). A linearly ramped switching time from 5 to 40 s was applied for 20 h. The gels were stained with ethidium bromide and photographed in a UV transilluminator. E. coli O18ac:H31 isolates recovered from a chicken and a calf, kindly provided by Flemming Scheutz, Statens Serum Institut, Copenhagen, Denmark, were included as controls for RAPD-PCR and PFGE.
Data analysis. Following an analysis of the profiles derived from RAPD and PFGE, the relatedness among the patterns was estimated by the proportions of shared bands after applying Jaccard's similarity coefficient. Data recording and calculations were performed using the RAPDistance program, version 1.03 (1). The resulting matrix of pairwise distance was used to generate a phenogram based on the unweighted pair group method with arithmetic mean, included in the MEGA software (11).
|
|
|---|
Non-lactose- and -sorbitol-fermenting E. coli O18ac:H31 isolates were recovered from outbreak cases. All the isolates from the outbreak were positive for ehl1. Restriction enzyme digestion using BclI confirmed that the expected restriction PCR fragments of 111 and 84 bp were observed (Fig. 1). In addition, isolates were resistant to ampicillin and cloramphenicol. These strains showed low adherence properties for HeLa cells, without any recognized pattern. During the prevalence study, E. coli isolates that did not ferment lactose or sorbitol were recovered from 11 of 16 (68.7%) inpatients. Five out of 11 isolates were derived from patients associated with the outbreak who were still hospitalized (cases A, B, C, D, and G), while the remaining six isolates were recovered from asymptomatic infants (cases H to M). E. coli isolates with the same biochemical characteristics were also recovered from 4 of 33 staff members examined, and all were asymptomatic. Of these, one was serotyped as an E. coli O18ac:H31 (case N) and a second was E. coli O81:HNM (case O). The remaining two isolates were not serotyped. Eight out of 15 isolates, derived from cases H to O, recovered during the prevalence study (six from inpatients not associated with the outbreak and two from staff) were fully characterized. All of the strains from the inpatients in the prevalence study and one of the two from the staff were identical to those isolated during the outbreak when serotype, antimicrobial susceptibility, and virulence factors were analyzed. The isolate from a nurse was serotyped as E. coli O81:HNM, was resistant to ampicillin, and was negative for all virulence factors studied, including ehl1.
![]() View larger version (56K): [in a new window] |
FIG. 1. PCR detection of E. coli enterohemolysin ehl1. Lanes 1 and 5, 100-bp ladder (Life Technologies, Rockville, Md.); lane 2, O18ac:H31 (case A); lane 3, BclI digestion of O18ac:H31 PCR amplification product; and lane 4, O81:HNM (case N).
|
![]() View larger version (104K): [in a new window] |
FIG. 2. RAPD profiles of E. coli strains recovered from the diarrhea outbreak and the prevalence study obtained with primer 258. Lanes 1 and 20, 100-bp DNA ladder (Promega); lanes 2 to 15, E. coli O18ac:H31 strains from the outbreak and prevalence study; lane 16, E. coli O81:HNM from the nurse; lane 17, a chicken isolate of E. coli O18ac:H31; lane 18, a calf isolate of E. coli O18ac:H31; and lane 19, no template. Chicken and calf isolates were unrelated to the outbreak.
|
![]() View larger version (126K): [in a new window] |
FIG. 3. PFGE patterns of E. coli O18ac:H31 isolates recovered from the diarrhea outbreak and the prevalence study in a neonatal nursery ward. DNA from isolates were digested with the restriction enzyme XbaI. Lanes 1, 11 and 20, lambda molecular size marker ladder (Bio-Rad Laboratories); lanes 2 to 10, 12 to 15, and 17, E. coli O18ac:H31 isolates from the outbreak and prevalence study; lane 16, E. coli O81:HNM isolate from a nurse attending the ward; lane 18, a chicken isolate of E. coli O18ac:H31; and lane 19, a calf isolate of E. coli O18ac:H31. Chicken and calf isolates were unrelated to the outbreak.
|
|
|
|---|
In this study, the premature status of the infants may offer explanation for the outbreak of bloody diarrhea associated with an E. coli O18ac:H31 strain producing ehl1; however, it should be noted that there were premature infants in the prevalence study who excreted the organism without symptoms. One hypothesis could be that the association of low birth weight with premature status in infants constitutes a higher risk factor for the development of enteric illness. It has also been postulated that hand carriage by health care workers could be one mode of transmission of the bacteria, given that the patients usually have common caregivers and that their beds were close to each other (6).
Investigations using colony blot DNA hybridization showed that 26 of 357 (7%) of E. coli strains were ehl1 positive and that 50% of these belonged to E. coli serotype O26 (18). The isolates from the present outbreak were characterized as non-lactose and -sorbitol fermenting and were serotyped as E. coli O18ac:H31. RAPD-PCR and PFGE results established the clonal relationship among the isolates and suggested a nosocomial spread within the nursery. This report on a major outbreak of enteric disease in a children's ward in Argentina caused by E. coli O18ac:H31 is the first recorded outbreak associated with this serotype and possessing the present virulence factor.
Serogroup E. coli O18 with a capsular K1 antigen is usually associated with septicemia or meningitis. The strains in this outbreak were K1 negative; however, one case of septicemia was detected. The E. coli O18ac:H31 strains isolated were capable of rapid colonization; indeed, the patient with NEC who died on the 3rd day after birth was fecal culture positive. The organism spread rapidly throughout the hospital ward, and during the prevalence study performed a month after the index case, the same strain confirmed by clonal analysis was recovered from a majority of the inpatients in the ward. Most of the inpatients continued to excrete the organism at the time of discharge, having carried the pathogen for at least 18 days (mean = 28.3 days). This suggested a high capacity for the organism to persist in the bowel. After the infected patients were discharged from the hospital, the strain was not isolated from any newborn patients or staff members. This outbreak occurred in spite of strict rules for preventing nosocomial infections. Following this outbreak, cross-infection prevention protocols were improved and rigorously enforced. Since then, prevalence studies performed weekly, including culture of stools, have yielded no isolates and no new cases of disease due to this pathogen.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»